GlobalData on MSN11h
MHRA approves trofolastat for prostate cancer diagnostic imagingTrofolastat is a prostate-specific membrane antigen-targeting agent cleared for use with Technetium-99m for cancerous lesion ...
Nuclear fusion offers limitless energy potential. UKAEA's initiatives focus on overcoming challenges to make fusion a viable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback